VVOS
Vivos Therapeutics, Inc. Common Stock
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Best Medical Devices Stocks 2026 →
Vivos Therapeutics (VVOS) Stock: Buy, Sell, or Hold?
$0.05
0.00 (-5.10%)
▼
5d:
-44.9%
30d:
-59.25%
90d:
-80.49%
Open in Live Scanner
70/30 Portfolio Builder
Last Earnings: Nov 18, 2026
Updated Nov 20, 12:00 AM ET
QUANTITATIVE VERDICT
WAIT
LOW Confidence (53%)
Quality Score
37/100
Position
OVERSOLD
30-Day Fair Range
$0.09 – $0.14
Position: OVERSOLD
Forward P/E & Valuation
-0.1x
Next 12M consensus est.
Wall Street Target
$1.93
+3464.8% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$0.05 / $0.10
Trend: Strong Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
⏸️ WAIT FOR STABILIZATION: VVOS is down 44.9% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
Get Alerted When VVOS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: VVOS is currently trading at $0.05, which is considered oversold relative to its 30-day fair value range of $0.09 to $0.14.
Technical Outlook: Technically, VVOS is in a strong downtrend. Immediate support is located at $0.05, while resistance sits at $0.10. Short-term momentum is weak, with the stock down 5.1% recently.
Market Sentiment: VVOS scores 25/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $1.93 (+3464.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, VVOS is in a strong downtrend. Immediate support is located at $0.05, while resistance sits at $0.10. Short-term momentum is weak, with the stock down 5.1% recently.
Market Sentiment: VVOS scores 25/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $1.93 (+3464.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$0.09 -
$0.14
Company Quality Score
37/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
52.6%
Trading Range & Key Levels
30-Day Trading Range
$0.09 -
$0.14
Current vs Trading Range
OVERSOLD
Support Level
$0.05
Resistance Level
$0.10
Current Trend
Strong Downtrend
Technical data as of
Nov 20, 2026
Institutional Signals, 13F Whale Activity & Setup Structure
Quantitative Research Feed
Phase & Gamma Walls
BREAKDOWN
Days in Phase:
113d (50% conf)
Quantitative Signal Breakdown
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-5.1%)
- BULLISH: Trading 3464.8% below Wall St target ($1.93)
- WARNING: Composite score 37/100 in the bottom quintile — this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
-0.07
Wall Street Target
$1.93
(+3464.8%)
Revenue Growth (YoY)
34.9%
Profit Margin
-121.8%
Share VVOS Analysis
Share this live VVOS analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (VVOS)
Bullish
2 Retail Mentions
Reddit / WSB Comments
1
Bearish
Retail Stream Volume
1 msgs
24h retail stream
Last Tracked
Nov 17, 2026
Daily AI digest
AI Retail Discussion Summary:
Vivos Therapeutics reported a 24% increase in revenue for Q3 2026, with a reduced operating loss and cost savings. The company regained compliance with Nasdaq's stockholders' equity requirement.
Key Retail Themes:
Financial improvement
Cost reduction
Aggregated from r/wallstreetbets, r/stocks & retail trader streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 22, 2026 5:57 AM ET
Data refreshes hourly during market hours. Next update: 6:57 AM
Data refreshes hourly during market hours. Next update: 6:57 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is VVOS showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
DXCM
DexCom Inc |
STRONG BUY
29 analysts |
$99 | 51 HOLD |
|
EW
Edwards Lifesciences Corp |
STRONG BUY
30 analysts |
$113 | 44 HOLD |
|
ABT
Abbott Laboratories |
STRONG BUY
28 analysts |
$119 | 47 HOLD |
|
SYK
Stryker Corporation |
STRONG BUY
30 analysts |
$339 | 43 HOLD |
|
BSX
Boston Scientific Corp |
BUY
31 analysts |
$50 | 54 HOLD |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive VVOS Research Pages
VVOS Technical Chart
VVOS Price Prediction
VVOS Intrinsic Value DCF
VVOS Earnings Date
VVOS Investment Advisor
VVOS Fair Price Analyzer
VVOS Target Price Playground
VVOS 5-Day Options Simulator
VVOS LEAP Simulator
VVOS Supply Chain Tear-Down
Engineering R&D & Supply-Chain Velocity Hub
AI Chip Cost & Reticle Wall Visualizer
House Thesis Scoreboard & Risk Guard
VVOS Competitors
Part B: Tradestie Flagship Market Scanners